BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15734070)

  • 1. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan.
    Wang ST; Lee LT; Chen LS; Chen TH
    Vaccine; 2005 Mar; 23(16):1973-80. PubMed ID: 15734070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R; Assantachai P; Wasi C; Puthavatana P; Kositanont U
    J Med Assoc Thai; 2005 Feb; 88(2):256-64. PubMed ID: 15962680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could a federal program to promote influenza vaccination among elders be cost-effective?
    Patel MS; Davis MM
    Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity.
    Voordouw BC; van der Linden PD; Simonian S; van der Lei J; Sturkenboom MC; Stricker BH
    Arch Intern Med; 2003 May; 163(9):1089-94. PubMed ID: 12742808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination.
    Wang CS; Wang ST; Lai CT; Lin LJ; Lee CT; Chou P
    Clin Infect Dis; 2004 Dec; 39(11):1604-10. PubMed ID: 15578359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years.
    Esposito S; Marchisio P; Bosis S; Lambertini L; Claut L; Faelli N; Bianchi C; Colombo GL; Principi N
    Vaccine; 2006 Jan; 24(5):629-35. PubMed ID: 16157429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan.
    Hoshi SL; Kondo M; Honda Y; Okubo I
    Vaccine; 2007 Aug; 25(35):6511-21. PubMed ID: 17681651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
    Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2010 Jul; 29(169):37-40. PubMed ID: 20712246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of influenza vaccination on seasonal mortality in the US elderly population.
    Simonsen L; Reichert TA; Viboud C; Blackwelder WC; Taylor RJ; Miller MA
    Arch Intern Med; 2005 Feb; 165(3):265-72. PubMed ID: 15710788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage.
    Rizzo C; Viboud C; Montomoli E; Simonsen L; Miller MA
    Vaccine; 2006 Oct; 24(42-43):6468-75. PubMed ID: 16876293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
    Cai L; Uchiyama H; Yanagisawa S; Kamae I
    Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An economic evaluation of strategy for expanding influenza vaccination in Japan].
    Hara Y
    Nihon Rinsho; 2003 Nov; 61(11):2013-8. PubMed ID: 14619447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of influenza vaccination on major cause-specific mortality.
    Wang CS; Wang ST; Lai CT; Lin LJ; Chou P
    Vaccine; 2007 Jan; 25(7):1196-203. PubMed ID: 17097773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is routine influenza immunization indicated for people over 65 years of age? An affirmative view.
    Thompson MP
    J Fam Pract; 1988 Feb; 26(2):211-4. PubMed ID: 3339325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predictors of influenza vaccination among frail, community-living elderly patients: an international observational study.
    Landi F; Onder G; Carpenter I; Garms-Homolova V; Bernabei R
    Vaccine; 2005 Jun; 23(30):3896-901. PubMed ID: 15917110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.